Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Si-Qi Li, Lan-Ping Xu, Yu Wang, Xiao-Hui Zhang, Huan Chen, Yu-Hong Chen, Feng-Rong Wang, Wei Han, Yu-Qian Sun, Chen-Hua Yan, Meng Lv, Fei-Fei Tang, Xiao-Dong Mo, Yan-Rong Liu, Kai-Yan Liu, Ying-Jun Chang, Xiao-Jun Huang

Blood (2022) 140 (5): 516–520.

https://doi.org/10.1182/blood.2021014604

Published: 2022

Includes: Supplemental data

Journal Articles

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

Ning Ma, Lan-Ping Xu, Xiaohui Zhang, Yu Wang, Huan Chen, Wei Han, Yuqian Sun, Chenhua Yan, Fei-Fei Tang, Xiaodong Mo, Yan-Rong Liu, Kaiyan Liu, Xiao Jun Huang, Ying-Jun Chang

Blood (2021) 138 (Supplement 1): 2880.

https://doi.org/10.1182/blood-2021-149088

Published: 2021

Journal Articles

A Clinical Study of 15 Acute Leukemia Patients with Plasmacytoid Dendritic Cells Expansion

Ya-Lan Zhou, Yan Wei, Xiaohong Liu, Jing Wang, Jinsong Jia, Hong-Xia Shi, Ying-Jun Chang, Xiao-Su Zhao, Yan-Rong Liu, Guo-Rui Ruan, Xiao-Jun Huang, Hao Jiang

Blood (2021) 138 (Supplement 1): 4468.

https://doi.org/10.1182/blood-2021-149623

Published: 2021

Journal Articles

Dead/H-Box Helicase 11 ( DDX11 ) Mutations Correlate with Increased Relapse Risk in Persons with Acute Myeloid Leukaemia and Promote Proliferation and Survival of Human AML Cells in Vitro and in Immune Deficient Mice

Blood (2019) 134 (Supplement_1): 2732.

https://doi.org/10.1182/blood-2019-127831

Published: 2019

Journal Articles

Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3- itd Mutation

Blood (2019) 134 (Supplement_1): 1421.

https://doi.org/10.1182/blood-2019-127937

Published: 2019

Journal Articles

Osteoclast Stimulatory Transmembrane Protein ( OCSTAMP ) mRNA Levels and Clinical Variables in Persons with Plasma Cell Myeloma

Ya-Lan Zhou, MD, Jin Lu, Robert Peter Gale, Shen-Miao Yang, Li-Xin Wu, Jin-Lan Li, Ya-Zhen Qin, Yan-Rong Liu, Hao Jiang, Qian Jiang, MD, Xiaohui Zhang, MD, Lan-Ping Xu, Kai-Yan Liu, Xiao-Jun Huang, Guorui Ruan

Blood (2018) 132 (Supplement 1): 5264.

https://doi.org/10.1182/blood-2018-99-116883

Published: 2018

Journal Articles

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Hong-Hu Zhu, Yan-Rong Liu, Jin-Song Jia, Ya-Zhen Qin, Xiao-Su Zhao, Yue-Yun Lai

Blood (2018) 131 (26): 2987–2989.

https://doi.org/10.1182/blood-2018-02-834051

Published: 2018

Includes: Supplemental data

Journal Articles

Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia

Li-Xin Wu, Run-Qing Lu, Kai-Yan Liu, Robert Peter Gale, MD ScD, PhD, Qi Zheng, Jiao Zhou, Jin-Lan Li, Shu-Juan Wang, Hao Jiang, MD, Qian Jiang, MD, Bin Jiang, Xiao-Hui Zhang, MD, Lan-Ping Xu, Yue Wang, Cheng-Li Song, Ya-Zhen Qin, Yan-Rong Liu, Xiao-Jun Huang, MD, Guo-Rui Ruan

Blood (2017) 130 (Supplement 1): 3986.

https://doi.org/10.1182/blood.V130.Suppl_1.3986.3986

Published: 2017

Journal Articles

Overexpression of Cysteine and Glycine-Rich Protein 2 in Bone Marrow As a Novel Biomarker in Adult B-Cell Acute Lymphoblastic Leukemia

Shu-Juan Wang, Wei-Min Wang, Wen-Yi Lu, Ya-Zhen Qin, Yue-Yun Lai, Yan-Rong Liu, Xiao-Jun Huang, Kai-Yan Liu, Guo-Rui Ruan

Blood (2016) 128 (22): 5271.

https://doi.org/10.1182/blood.V128.22.5271.5271

Published: 2016

Journal Articles

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Ya-Zhen Qin, Honghu Zhu, Qian Jiang, Hao Jiang, Le-Ping Zhang, Jin-Lan Li, Ling-Di Li, Yan-Rong Liu, Yue-Yun Lai, Hong-Xia Shi, Bin Jiang, MD, Xiao-Jun Huang, MDPhD

Blood (2014) 124 (21): 1000.

https://doi.org/10.1182/blood.V124.21.1000.1000

Published: 2014

Journal Articles

CD34 + CD38 - CD58 - leukemia-Propagating Cells at Diagnosis Could Identify Patients at High-Risk for Relapse in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Yuan Kong, MDPhD, Lan-Ping Xu, Yan-Rong Liu, Ya-Zhen Qin, Yu-Qian Sun, Yu Wang, Huan Chen, Hao Jiang, Qian Jiang, Ying-Jun Chang, PhD, Xiao-Jun Huang, MDPhD

Blood (2014) 124 (21): 3795.

https://doi.org/10.1182/blood.V124.21.3795.3795

Published: 2014

Journal Articles

In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1 -based MRD monitoring, rather than c-KIT mutations, allows further risk stratification

Yu Wang, De-Pei Wu, Qi-Fa Liu, Ya-Zhen Qin, Jing-Bo Wang, Lan-Ping Xu, Yan-Rong Liu, Hong-Hu Zhu, Jia Chen, Min Dai, Xiao-Jun Huang

Blood (2014) 124 (12): 1880–1886.

https://doi.org/10.1182/blood-2014-03-563403

Published: 2014

Journal Articles

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Yuan kong, MD, PhD, Ying-Jun Chang, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Qian Jiang, Hao Jiang, Ya-Zhen Qin, MS, Jing Wang, Hong-Hu Zhu, MD, Yue-Yun Lai, Lanping Xu, Dai-Hong Liu, MD, PhD, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 354.

https://doi.org/10.1182/blood.V122.21.354.354

Published: 2013

Journal Articles

Low WT1 Expression At Diagnosis Is a Strong Predictor On Poor Outcome In Patients With t(8;21) Acute Myeloid Leukemia

Ya-Zhen Qin, MS, Hong-Hu Zhu, MD, Qian Jiang, Dai-Hong Liu, MD, PhD, Hao Jiang, Lan-Ping Xu, MD, Huan Chen, Yu Wang, MD, Xiao-hui Zhang, MD, PhD, Jun-Yue Chai MM, Li-Ru Wang, MD, Yan-Rong Liu, MS, Xiao-Jun Huang, MD, PhD

Blood (2013) 122 (21): 1346.

https://doi.org/10.1182/blood.V122.21.1346.1346

Published: 2013

Journal Articles

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

Blood (2013) 121 (20): 4056–4062.

https://doi.org/10.1182/blood-2012-11-468348

Published: 2013

Includes: Supplemental data

Journal Articles

CD34 Expression On the Blasts of Bone Marrow Is a Novel Predictor of Poor Prognosis Independent of FlT3-ITD in Acute Myeloid Leukemia with NPM1-Mutation.

Hong-Hu Zhu, Yan-Rong Liu, Hao Jiang, Jin Lu, MD, Yazhen Qin, Qian Jiang, Xiaojun Huang

Blood (2012) 120 (21): 2491.

https://doi.org/10.1182/blood.V120.21.2491.2491

Published: 2012

Journal Articles

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

Xiao-hui Zhang, MD, PhD, Guo-xiang Wang, MD, Yan-rong Liu, MD, Lan-Ping Xu, MD, Kai-Yan Liu, MD, Wei Han, MD, Yu Wang, MD, Hai-xia Fu, MD, Meng Lv, MD, Min Wang, MD, Yi Zhou, MD, Xiao-Jun Huang, MD

Blood (2012) 120 (21): 3077.

https://doi.org/10.1182/blood.V120.21.3077.3077

Published: 2012

Journal Articles

The PRAME and WT1 Transcripts Constitute a Good Molecular Marker Combination for Monitoring Minimal Residual Disease in Myelodysplastic Syndromes

Yazhen Qin, Honghu Zhu, PhD, Yan-rong Liu, MD, Ya-zhe Wang, Hong-Xia Shi, Yue-yun Lai, Lan-Ping Xu, MD, Daihong Liu, Xiaojun Huang

Blood (2012) 120 (21): 3853.

https://doi.org/10.1182/blood.V120.21.3853.3853

Published: 2012

Journal Articles

Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Chen-Hua Yan, Dai-Hong Liu, Kai-Yan Liu, Lan-Ping Xu, Yan-Rong Liu, Huan Chen, Wei Han, Yu Wang, Ya-Zhen Qin, Xiao-Jun Huang

Blood (2012) 119 (14): 3256–3262.

https://doi.org/10.1182/blood-2011-09-380386

Published: 2012

Journal Articles

Leukemia Initiating Cells: New Markers for Minimal Residual Disease Monitoring in B-Precursor Acute Lymphoblastic Leukemia

Yuan Kong, MD, PhD, Yan-rong Liu, MD, Le Hao, Ya-zhe Wang, Kai-yan Liu, MD, PhD, Xiao-jun Huang, MD, PhD

Blood (2011) 118 (21): 2528.

https://doi.org/10.1182/blood.V118.21.2528.2528

Published: 2011

NARROW

An LSC-based MRD assay to complement the traditional MFC method for prediction of AML relapse: a prospective study

Prevalence and Risk Factors of Antibodies to Class I and II Human Leukocyte Antigens in Haploidentical Allograft Candidates: A Prospective Study on 3805 Subjects

A Clinical Study of 15 Acute Leukemia Patients with Plasmacytoid Dendritic Cells Expansion

Dead/H-Box Helicase 11 ( DDX11 ) Mutations Correlate with Increased Relapse Risk in Persons with Acute Myeloid Leukaemia and Promote Proliferation and Survival of Human AML Cells in Vitro and in Immune Deficient Mice

Genomic Landscape and Risk-Stratification for De Novo Acute Myeloid Leukemia with Normal Cytogenetics and No NPM1 or FLT3- itd Mutation

Osteoclast Stimulatory Transmembrane Protein ( OCSTAMP ) mRNA Levels and Clinical Variables in Persons with Plasma Cell Myeloma

Oral arsenic and all- trans retinoic acid for high-risk acute promyelocytic leukemia

Mutation Topology of Adult B-Cell Acute Lymphoblastic Leukaemia

Overexpression of Cysteine and Glycine-Rich Protein 2 in Bone Marrow As a Novel Biomarker in Adult B-Cell Acute Lymphoblastic Leukemia

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

CD34 + CD38 - CD58 - leukemia-Propagating Cells at Diagnosis Could Identify Patients at High-Risk for Relapse in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1 -based MRD monitoring, rather than c-KIT mutations, allows further risk stratification

CD34 + CD38 - CD58 - Candidate Leukemia-Initiating Cells Are Clinically Relevant With The Unfavorable Prognosis In Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Low WT1 Expression At Diagnosis Is a Strong Predictor On Poor Outcome In Patients With t(8;21) Acute Myeloid Leukemia

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

CD34 Expression On the Blasts of Bone Marrow Is a Novel Predictor of Poor Prognosis Independent of FlT3-ITD in Acute Myeloid Leukemia with NPM1-Mutation.

Prolonged Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) and Its Association with an Increase in CD8+ CX3CR1+ Cells in Bone Marrow.

The PRAME and WT1 Transcripts Constitute a Good Molecular Marker Combination for Monitoring Minimal Residual Disease in Myelodysplastic Syndromes

Risk stratification–directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation

Leukemia Initiating Cells: New Markers for Minimal Residual Disease Monitoring in B-Precursor Acute Lymphoblastic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only